Accelerate AMI Diagnostic Decisions: The Efficiency Advantages of reOpenTest Cardiac Marker Panel Tests
Time is myocardium! Every minute is crucial. Learn more about how our cardiac panel (cTnI/Myo/CK-MB) test solution provides more comprehensive myocardial injury information through a single test, helping key customers such as emergency departments significantly improve the diagnostic efficiency of acute myocardial infarction (AMI) and buy valuable time for life.
Get a quote for cardiac panel test productsChallenges in Rapid AMI Diagnosis and the Value of Panel Tests
Rapid and accurate diagnosis of acute myocardial infarction (AMI) is key to initiating timely reperfusion therapy and saving lives. However, single cardiac marker testing has limitations: early markers (such as myoglobin Myo) rise rapidly but lack specificity, while highly specific markers (such as cardiac troponin cTnI) appear later. Relying on multiple single tests is not only time-consuming but can also delay optimal treatment and increase the workload of the emergency department.
More Comprehensive Myocardial Injury Information
Our panel test solution combines markers that reflect different stages of injury: early (Myo), intermediate (CK-MB), and late (cTnI). A single test can capture the dynamic changes of myocardial injury in its entirety, providing a more reliable diagnostic basis.
Significantly Reduce Diagnosis Time
No need to wait for multiple rounds of single test results. By obtaining multiple key indicators at once, the reOpenTest panel test solution can shorten the diagnosis time to within 15 minutes, greatly accelerating the clinical decision-making process and truly buying time to save lives.
Optimize Emergency Department Workflow
Reduce the number of sample processing, testing rounds, and result waiting times, effectively simplifying the workflow in emergency departments and POCT environments, reducing operational complexity, and improving overall diagnosis and treatment efficiency and resource utilization.
Core Advantages of reOpenTest Cardiac Panel Test Solutions
Optimized Marker Combination
We offer the clinically widely recognized "Cardiac Triple Test" (cTnI/Myo/CK-MB) panel test, as well as other efficient combinations customized according to clinical needs, comprehensively meeting the needs of different diagnostic strategies and complying with relevant clinical guideline recommendations.
High Sensitivity and Specificity
Based on reOpenTest's mature technology platform and strict quality control system, we ensure that each marker test achieves excellent sensitivity and specificity, providing clinicians with highly reliable diagnostic results.
Get Results Quickly in 15 Minutes
Using advanced immunochromatography technology, accurate test results can be provided within 15 minutes, fully meeting the stringent requirements for rapid diagnosis in emergency departments, chest pain centers, and other scenarios.
Perfectly Adapted for Point-of-Care Testing (POCT)
The operation process is simple and convenient, without the need for large professional equipment or complex operation training, and can be quickly deployed and applied in a variety of point-of-care testing scenarios such as emergency rooms, ambulances, and community clinics.
Our Cardiac Marker Panel Test Products
Cardiac Triple Test Combo Kit (cTnI/Myo/CK-MB)
The classic gold standard combination for early AMI diagnosis, providing comprehensive dynamic information on myocardial injury in a single test to help rapid and accurate clinical decision-making.
Learn MoreCardiac Troponin I (cTnI) Rapid Test Kit (Whole Blood/Serum/Plasma)
An immunochromatographic rapid test tool for the qualitative detection of cardiac troponin I (cTnI), suitable for whole blood, serum or plasma samples. It can be used for the early auxiliary diagnosis of acute myocardial infarction (AMI). The results are presented quickly within 10–15 minutes. It is easy to operate, sensitive and reliable.
Learn MoreEmpowering Distributors: How to Promote the Efficiency Advantages of Cardiac Panel Tests to Customers Such as Emergency Departments?
- Highlight Time Value: Emphasize the rapid testing and decision-making advantages of the reOpenTest panel test solution within the AMI golden treatment "time window," directly correlating with patient prognosis.
- Contrast Single Test Limitations: Clearly explain the significant advantages of panel tests compared to single tests in providing comprehensive myocardial injury information, avoiding missed diagnoses and misdiagnoses, and shortening overall diagnosis time.
- Showcase Hard Data: Provide clinical validation data on the product's high sensitivity and high specificity, as well as proof of convenience and stability in POCT scenarios, to build customer trust.
- Align with Clinical Standards: Combine national chest pain center construction standards or related clinical guidelines to illustrate how the reOpenTest panel test solution can help hospitals meet standards and improve diagnosis and treatment levels.
- Emphasize Cost-Effectiveness: Analyze how panel tests can help hospitals control costs by reducing repeat testing, optimizing processes, and shortening hospital stays.
Win the Emergency Market with Efficient Cardiac Panel Test Solutions!
reOpenTest Cardiac Marker Panel Test Reagents are your powerful weapon to develop the emergency market, serve chest pain centers, and improve AMI diagnostic efficiency. We offer competitive products and comprehensive market support. Contact us now to learn more about cooperation details.